Molecular food safety testing company Clear Labs announced on Wednesday that it has raised $60 million in an oversubscribed Series C financing round to advance its genomic surveillance products for SARS-CoV-2.
Read more
Portfolio
The companies we've backed from seed to category leader.
View Portfolio
Insights
More from the team — what we're seeing, thinking, and still questioning.
